Posts by Jeanny Aragon-Ching
Study Finds New Therapy Effective for Common, Advanced Bladder Cancer
Following standard chemotherapy, Avelumab was found to increase the overall survival of patients with advanced urothelial bladder cancer. According to the North American Association of Central Cancer Registries, more than 80,000 Americans will be diagnosed with bladder cancer in 2022 with an anticipated loss of 17,000 patients to the disease. Most of these cases are…
Read MoreDo You Know the Warning Signs of Bladder Cancer?
Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile. (Originally published May 15, 2017) Bladder cancer…
Read MoreNew Treatment Options Are Changing the Landscape for Prostate Cancer Patients
Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Prostate cancer is an extremely common disease. More than 3 million…
Read MoreTreatment Innovation for Patients with Prostate, Bladder and Kidney Cancers
Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. The doctors and researchers at the Inova Schar Cancer…
Read MoreFrom Research to Results: Advances in Genitourinary Cancer Treatment
Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile. This February, I’ll be traveling to…
Read MoreProstate Cancer Is the Second Most Common Cancer in American Men
Dr. Aragon-Ching serves as the Clinical Program Director of Genitourinary Cancers within the Inova Dwight and Martha Schar Cancer Institute. Schedule an appointment or learn more about Dr. Aragon-Ching. Prostate Cancer Awareness Month Prostate cancer is the most common cancer, apart from skin cancer, that occurs among American men. In 2015 alone, a projected 220,000…
Read More